- Home
- SCCO vs BMY Comparison
SCCO vs BMY Comparison
Compare SCCO & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SCCO | BMY |
|---|---|---|
| Founded | 1952 | 1887 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Mining | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 121.3B | 110.2B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SCCO | BMY |
|---|---|---|
| Price | $157.82 | $56.68 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 13 |
| Target Price | ★ $122.56 | $56.31 |
| AVG Volume (30 Days) | 1.1M | ★ 15.3M |
| Earning Date | 02-11-2026 | 02-05-2026 |
| Dividend Yield | 2.23% | ★ 4.63% |
| EPS Growth | ★ 25.54 | N/A |
| EPS | ★ 4.67 | 2.97 |
| Revenue | $12,334,600,000.00 | ★ $48,034,000,000.00 |
| Revenue This Year | $13.43 | $0.27 |
| Revenue Next Year | $6.38 | N/A |
| P/E Ratio | $34.24 | ★ $18.32 |
| Revenue Growth | ★ 12.70 | 1.26 |
| 52 Week Low | $72.75 | $42.52 |
| 52 Week High | $161.59 | $63.33 |
Technical Indicators
Market Signals| Indicator | SCCO | BMY |
|---|---|---|
| Relative Strength Index (RSI) | 67.19 | 70.91 |
| Support Level | $142.00 | $52.06 |
| Resistance Level | $161.59 | $55.04 |
| Average True Range (ATR) | 3.53 | 0.93 |
| MACD | 1.00 | -0.10 |
| Stochastic Oscillator | 81.99 | 94.66 |
Price Performance
Historical ComparisonAbout SCCO Southern Copper Corporation
Southern Copper Corp is an integrated producer of copper and other minerals and operates the mining, smelting, and refining facilities in Peru and Mexico. Its production includes copper, molybdenum, zinc, and silver. The company operates through the following segments: Peruvian operations, Mexican open-pit operations, and Mexican underground mining operations. It generates the majority of its revenue from the sale of copper and the rest from the sale of non-copper products, such as molybdenum, silver, zinc, lead, and gold. The company's geographical segments are The Americas, Europe, and Asia.
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.